NSG 533 - Advanced Pathophysiology
Exam 1 - Module One 2025 update
|comprehensive questions and verified
answers |GRADE A+!!
Pathophysiology ANS: the study of human physiologic dysfunction in disease
etiology, epidemiology, pathogenesis, clinical manifestations, and outcomes ANS: What are the five
components of disease?
epidemiology ANS: risk factors and distribution in populations
etiology ANS: causative mechanisms
pathogenesis ANS: disease mechanisms
clinical manifestations ANS: signs, symptoms and diagnostic criteria
outcomes ANS: cure, remission, chronicity, or death
etiology ANS: The "why" of the disease, what is the reason for it. May be complex or straight forward
idiopathic ANS: also called cryptogenic, known in cause or origin
iatrogenic ANS: occurs as a results of a medical or surgical intervention (e.g. yeast infection after getting
antibiotics)
, epidemiology ANS: this looks at the patterns of disease among groups or populations. this complement
represents the relationship between numerous population characteristics and looks at the incidence or
prevalence of diease
incidence ANS: the number of new cases occurring in a given population with a given time period -
usually a year. can be expressed as a percentage
prevalence ANS: involves the number of cases existing (both old and new) at a given time period. Can
be expressed as a percentage
pathogenesis ANS: involves the sequence of events that occurs between the stimulus events and the
manifestations of the disease.
clinical manifestations ANS: it is what tells an individual and their HCP that something is wrong. Also
called "signs and symptoms'
primary prevention ANS: directed towards preventing the initial occurrence of a disorder
Secondary and tertiary prevention ANS: (2 terms) these seek to arrest or retard existing disease and its
effect through early detection and appropriate treatment - or to reduce the occurrence of relapses and
the establishment of chronic conditions
at the cellular or sub-cellular level ANS: Where does all disease begin?
lethal (irreversible) and non-lethal (reversible) ANS: What are the two types of cell injury?
Exam 1 - Module One 2025 update
|comprehensive questions and verified
answers |GRADE A+!!
Pathophysiology ANS: the study of human physiologic dysfunction in disease
etiology, epidemiology, pathogenesis, clinical manifestations, and outcomes ANS: What are the five
components of disease?
epidemiology ANS: risk factors and distribution in populations
etiology ANS: causative mechanisms
pathogenesis ANS: disease mechanisms
clinical manifestations ANS: signs, symptoms and diagnostic criteria
outcomes ANS: cure, remission, chronicity, or death
etiology ANS: The "why" of the disease, what is the reason for it. May be complex or straight forward
idiopathic ANS: also called cryptogenic, known in cause or origin
iatrogenic ANS: occurs as a results of a medical or surgical intervention (e.g. yeast infection after getting
antibiotics)
, epidemiology ANS: this looks at the patterns of disease among groups or populations. this complement
represents the relationship between numerous population characteristics and looks at the incidence or
prevalence of diease
incidence ANS: the number of new cases occurring in a given population with a given time period -
usually a year. can be expressed as a percentage
prevalence ANS: involves the number of cases existing (both old and new) at a given time period. Can
be expressed as a percentage
pathogenesis ANS: involves the sequence of events that occurs between the stimulus events and the
manifestations of the disease.
clinical manifestations ANS: it is what tells an individual and their HCP that something is wrong. Also
called "signs and symptoms'
primary prevention ANS: directed towards preventing the initial occurrence of a disorder
Secondary and tertiary prevention ANS: (2 terms) these seek to arrest or retard existing disease and its
effect through early detection and appropriate treatment - or to reduce the occurrence of relapses and
the establishment of chronic conditions
at the cellular or sub-cellular level ANS: Where does all disease begin?
lethal (irreversible) and non-lethal (reversible) ANS: What are the two types of cell injury?
